期刊
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
卷 63, 期 1, 页码 -出版社
AMER SOC MICROBIOLOGY
DOI: 10.1128/AAC.01931-18
关键词
human simulated; pharmacodynamics; pharmacokinetics
资金
- Wockhardt Bio AG, Switzerland
Herein, we describe the in vivo efficacy of human-simulated WCK 5222 (cefepime-zidebactam) exposure against carbapenem-resistant Acinetobacter baumannii strains in a neutropenic murine thigh infection model. Five of the six isolates examined expressed OXA-23 or OXA-24. WCK 5222, despite showing MICs of 16 to 64 mg/liter, produced remarkable in vivo activity; human-simulated exposure showed a decline in the bacterial burden for all isolates (mean reduction, -2.09 +/- 1.01 log10 CFU/thigh), while a lack of activity was observed with cefepime and zidebactam monotherapies.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据